“…Studies that reported a G1/S arrest phenotype following nucleostemin-knockdown include those performed in U2OS cells (Dai et al, 2008;Ma and Pederson, 2007), SW1710 cells (Nikpour et al, 2009), HeLa cells (Sijin et al, 2004), PC-3 cells (Liu et al, 2010) and bone marrow-derived stromal stem cells (Jafarnejad et al, 2008). In contrast, the finding that nucleostemin-depleted cells are arrested at the G2/M phase has also been reported in several studies performed in U2OS cells (Meng et al, 2008), HeLa cells (Romanova et al, 2009), 5637 cells (Nikpour et al, 2009) and mouse embryonic fibroblast cells (MEFs) (Zhu et al, 2006). It is noted that the studies describing G1/S arrest used cells with either wild-type or mutant forms of p53, retinoblastoma, p16 and alternate reading frame (p14ARF) protein (both encoded by CDKN2A), and studies describing G2/M arrest also used cells with wild-type or mutant forms of p53, retinoblastoma, p16 and p14ARF.…”